Eli Lilly & Co. (LLY)
1009.52
-13.70
(-1.34%)
USD |
NYSE |
Feb 20, 16:00
1011.60
+2.08
(+0.21%)
After-Hours: 20:00
Eli Lilly Market Cap : 952.34B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 202.02B |
| Biogen, Inc. | 28.18B |
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Viking Therapeutics, Inc. | 3.586B |
| Moderna, Inc. | 19.49B |
Market Cap Related Metrics
| PE Ratio | 44.69 |
| PS Ratio | 14.11 |
| PEG Ratio | 0.4626 |
| Price to Book Value | 35.89 |
| Price to Free Cash Flow | 154.20 |
| Price | 1009.52 |
| Earnings Yield | 2.24% |
| PEGY Ratio | 0.4596 |
| Operating PE Ratio | 30.97 |
| Normalized PE Ratio | 40.69 |